Vaginal Infection Clinical Trial
Official title:
Performance Proof of The Norma-Sense Gen 3 - Wearing Study
NCT number | NCT01542606 |
Other study ID # | F-7-28.6-1 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2019 |
Est. completion date | December 2019 |
Verified date | August 2019 |
Source | Common Sense |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study was designed to validate the color appearance on the NORMA-SENSE gen 3 when comes into contact with vaginal secretions having an elevated pH level
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2019 |
Est. primary completion date | September 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. Women, age 18 years or greater with or without symptoms of vaginal infection. 2. Subject is ready to sign the informed consent form. Exclusion Criteria: 1. Subject is unable or unwilling to cooperate with study procedures. 2. Subject is currently participating in another clinical study. 3. Subject suffers from vaginal bleeding or is menstruating. 4. Subject that have had sexual relations within the last 12 hours. 5. Subject that applied local antiseptic or antibiotic or vaginal treatment within the last 3 days. 6. Subject that applied vaginal douching within 12 hours prior to the visit at the clinic. |
Country | Name | City | State |
---|---|---|---|
Israel | Lin Medical Center Clalit health care | Haifa |
Lead Sponsor | Collaborator |
---|---|
Common Sense |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | color status of the NORMA-SENSE gen 3 and the pH measurement. | agreement between the color status of the NORMA-SENSE gen 3 as reported by the subject after using the panty liners, and the pH measurement with Nitrazine paper. | 3 days | |
Secondary | physical comfort in using NORMA-SENSE gen 3 and the result reading clarity | the patient report regarding physical comfort in using NORMA-SENSE gen 3 and the result reading clarity including the ability to visualize and interpret the NORMA-SENSE gen 3 results. | 3 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00324246 -
Feasibility Study of the NEW NORMA-SENSE
|
Phase 3 | |
Recruiting |
NCT05021315 -
Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection
|
Phase 3 | |
Not yet recruiting |
NCT05997160 -
Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
|
||
Recruiting |
NCT05557318 -
Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
|
N/A | |
Completed |
NCT05044156 -
Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
|
||
Completed |
NCT00694928 -
Vaginal Infection Study 2
|
Phase 3 | |
Not yet recruiting |
NCT05590195 -
Effect of PreforPro® on Urinary and Vaginal Health
|
Phase 3 | |
Completed |
NCT03898726 -
Laparoscopic Versus Transvaginal Cuff Closure
|
N/A | |
Not yet recruiting |
NCT05806879 -
Impact of Maternity Napkins on the Incidence of Vaginal Infections in the Post-partum Period
|
N/A | |
Completed |
NCT02308007 -
Multi-Center Study of New Medications to Treat Vaginal Infections
|
Phase 3 | |
Completed |
NCT02308033 -
Multi-Center Study of New Medications to Treat Vaginal Infections
|
Phase 3 | |
Completed |
NCT02308046 -
Multi-Center Study of New Medications to Treat Vaginal Infections
|
Phase 3 | |
Completed |
NCT01599416 -
Influence of U-relax on Vaginal Health Promotion and HPV DNA Test Change From Positive to Negative
|
N/A | |
Recruiting |
NCT04719754 -
Epidemiology of Abnormal Vaginal Discharge During Pregnancy
|
||
Completed |
NCT03008421 -
Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy
|
N/A | |
Completed |
NCT03261804 -
Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users
|
||
Terminated |
NCT05788991 -
Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis
|
Phase 4 | |
Completed |
NCT01843166 -
Vaginal Estrogen With Pessary Treatment
|
N/A | |
Not yet recruiting |
NCT03532464 -
Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection
|
Phase 4 | |
Completed |
NCT01055106 -
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
|
Phase 2 |